What is Nowatch?
Nowatch is a health technology innovator focused on empowering individuals to manage their well-being through advanced tech tools. The company's flagship product, the NOWATCH, is a pioneering wearable device designed to measure and predict stress by tracking cortisol levels, aiming to preempt burnout. This screenless device features a customizable gemstone face and monitors various health metrics such as temperature, heart rate, movement, and sleep. Its predictive technology learns the wearer's patterns, providing alerts for potential stress triggers up to an hour in advance, thereby promoting mind-body balance and overall wellness.
How much funding has Nowatch raised?
Nowatch has raised a total of $8.7M across 1 funding round:
Series A
$8.7M
Series A (2022): $8.7M with participation from Chris Hall and Flow Ventures
Key Investors in Nowatch
Chris Hall
Chris Hall is an individual investor participating in the funding round.
Flow Ventures
Flow Ventures is a SR&ED consulting firm with unparalleled experience helping companies maximize their SR&ED refunds while minimizing their risk and time.
What's next for Nowatch?
With its recent major strategic investment, Nowatch is poised for significant scaling and further development of its stress-predictive wearable technology. The substantial capital infusion, totaling $8.7M, suggests a growth-oriented phase, likely enabling the company to expand its market reach, enhance its product's predictive capabilities, and potentially broaden its health metric tracking. This strategic backing from investors indicates strong confidence in Nowatch's mission to restore balance and enhance complete mind and body wellbeing through innovative health technology.
See full Nowatch company page
